EQUINIX INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that EQUINIX INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $1.56B | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | $1.52B | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | $1.47B | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | $1.44B | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | $1.42B | Feb 19, 2021 |
| FY2020 | Sep 30, 2019 | $1.40B | Feb 19, 2021 |
| FY2020 | Jun 30, 2019 | $1.38B | Feb 19, 2021 |
| FY2020 | Mar 31, 2019 | $1.36B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $1.31B | Feb 21, 2020 |
| FY2019 | Sep 30, 2018 | $1.28B | Feb 21, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.22B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $8.75B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $8.19B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $7.26B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $6.64B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $6.00B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $5.56B | Feb 18, 2022 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.20B | Feb 26, 2018 |
| FY2017 | Sep 30, 2017 | $1.15B | Feb 26, 2018 |
| FY2017 | Jun 30, 2017 | $1.07B | Feb 26, 2018 |
| FY2017 | Mar 31, 2017 | $949.53M | Feb 26, 2018 |
| FY2017 | Dec 31, 2016 | $942.65M | Feb 26, 2018 |
| FY2017 | Sep 30, 2016 | $924.68M | Feb 26, 2018 |
| FY2017 | Jun 30, 2016 | $900.51M | Feb 26, 2018 |
| FY2017 | Mar 31, 2016 | $844.16M | Feb 26, 2018 |
| FY2016 | Dec 31, 2015 | $730.46M | Feb 27, 2017 |
| FY2016 | Sep 30, 2015 | $686.65M | Feb 27, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $733.38M | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | $751.79M | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | $730.78M | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | $708.26M | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | $691.50M | Feb 19, 2021 |
| FY2020 | Sep 30, 2019 | $692.47M | Feb 19, 2021 |
| FY2020 | Jun 30, 2019 | $686.80M | Feb 19, 2021 |
| FY2020 | Mar 31, 2019 | $681.19M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $639.15M | Feb 21, 2020 |
| FY2019 | Sep 30, 2018 | $623.44M | Feb 21, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.35B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $815.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $969.00M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $705.00M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $500.19M | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | $50.99M | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | $66.69M | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | $133.30M | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | $118.79M | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | $125.00M | Feb 19, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.85B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $1.33B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $1.44B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $1.20B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $1.11B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $1.05B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $1.17B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $977.38M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $809.01M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $618.74M | Feb 22, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.91B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $3.25B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $3.22B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $2.96B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $2.55B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $2.31B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $1.99B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $1.82B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $1.44B | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $1.02B | Feb 22, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2010 | Dec 31, 2010 | $14.86M | Feb 25, 2011 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $40.14B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $35.09B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $32.65B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $30.31B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $27.92B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $27.01B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $23.97B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $20.24B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $18.69B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $12.61B | Feb 26, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.96B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $21.53B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $20.14B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $18.80B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $17.04B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $16.37B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $15.13B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $13.03B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $11.84B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $8.24B | Feb 26, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.16B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $13.53B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $12.49B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $11.51B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $10.88B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $10.63B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $8.84B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $7.22B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $6.85B | Feb 22, 2019 |
| FY2018 | Dec 31, 2016 | $4.37B | Feb 22, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.98B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $5.50B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $5.74B | Feb 11, 2026 |
| FY2025 | Dec 31, 2022 | $5.65B | Feb 11, 2026 |
| FY2024 | Dec 31, 2021 | $5.37B | Feb 12, 2025 |
| FY2023 | Dec 31, 2020 | $5.47B | Feb 16, 2024 |
| FY2021 | Dec 31, 2019 | $4.78B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $4.84B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $4.41B | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $2.99B | Feb 22, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.10B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $4.75B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $3.93B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $2.96B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $2.26B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $1.76B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $1.39B | Feb 19, 2021 |
| FY2020 | Jan 1, 2019 | $883.98M | Feb 19, 2021 |
| FY2020 | Dec 31, 2018 | $889.95M | Feb 19, 2021 |
| FY2018 | Jan 1, 2018 | $522.47M | Feb 22, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.73B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $3.08B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $2.10B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $1.91B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $1.54B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $1.60B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $1.87B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $606.17M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $1.41B | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $748.48M | Feb 22, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $15.33B | Feb 12, 2025 |
| FY2023 | Dec 31, 2023 | $13.84B | Feb 16, 2024 |
| FY2022 | Dec 31, 2022 | $12.88B | Feb 17, 2023 |
| FY2021 | Dec 31, 2021 | $11.72B | Feb 18, 2022 |
| FY2020 | Dec 31, 2020 | $10.63B | Feb 19, 2021 |
| FY2019 | Dec 31, 2019 | $10.40B | Feb 21, 2020 |
| FY2018 | Dec 31, 2018 | $9.89B | Feb 22, 2019 |
| FY2017 | Dec 31, 2017 | $8.47B | Feb 26, 2018 |
| FY2016 | Dec 31, 2016 | $5.31B | Feb 27, 2017 |
| FY2015 | Dec 31, 2015 | $5.25B | Feb 26, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 13 | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 8 | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | 10 | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | 7 | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | 5 | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | 1 | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | 1 | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | 1 | Feb 19, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 13 | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 8 | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | 10 | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | 7 | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | 5 | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | 1 | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | 1 | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | 1 | Feb 19, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 98.23M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 97.29M | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | 94.48M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | 92.62M | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | 90.57M | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | 89.13M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | 85.31M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | 80.72M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | 79.04M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | 71.41M | Feb 26, 2018 |